Contact this trialFirst, we need to learn more about you.
Alkylating agents
Pembrolizumab + Chemotherapy for Head and Neck Cancer
Recruiting3 awardsPhase 2
Chicago, Illinois
This trial aims to find out if a blood test can predict who will respond best to chemo + immunotherapy for head and neck cancer. It will last two years.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service